71 related articles for article (PubMed ID: 7587728)
21. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
22. CD4+/CD8+ lymphocyte patterns in renal transplant recipients receiving chronic methylprednisolone.
Tornatore KM; Reed K; Venuto RC
J Med; 1993; 24(2-3):98-112. PubMed ID: 8105017
[TBL] [Abstract][Full Text] [Related]
23. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
Wieneke H; Otte B; Lang D; Heidenreich S
Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
[TBL] [Abstract][Full Text] [Related]
24. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
Bock HA; Gallati H; Zürcher RM; Bachofen M; Mihatsch MJ; Landmann J; Thiel G
Transplantation; 1995 Mar; 59(6):830-40. PubMed ID: 7701577
[TBL] [Abstract][Full Text] [Related]
25. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
[TBL] [Abstract][Full Text] [Related]
26. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
27. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
28. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
29. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
30. Induction antibody therapy in kidney transplantation.
Padiyar A; Augustine JJ; Hricik DE
Am J Kidney Dis; 2009 Nov; 54(5):935-44. PubMed ID: 19682780
[TBL] [Abstract][Full Text] [Related]
31. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
[TBL] [Abstract][Full Text] [Related]
32. [Future perspectives of kidney transplant: towards a specific immunosuppression?].
Ortiz Arduan A; Gutiérrez JR; Méndez A; Ortiz A
Rev Clin Esp; 1989 Jun; 185(1):41-3. PubMed ID: 2672159
[TBL] [Abstract][Full Text] [Related]
33. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
Regan JF; Campbell K; Van Smith L; Schroeder TJ; Womble D; Kano J; Buelow R
Transpl Immunol; 1999 Jun; 7(2):115-21. PubMed ID: 10544442
[TBL] [Abstract][Full Text] [Related]
34. Comparison of polyclonal antibody sera for early prophylaxis following cardiac transplantation.
Bolling SF; Stirling MC; Miska P; Deeb GM
J Surg Res; 1989 Oct; 47(4):292-6. PubMed ID: 2671502
[TBL] [Abstract][Full Text] [Related]
35. OKT3-treated kidney transplant patients: monitoring of effects on peripheral blood mononuclear cells by using two-color flow cytometry.
Harford AM; Shopp GM; Ashmore LM; Seppelt JE; Mosdell DM; Gibel LJ; Sterling WA
Transplant Proc; 1988 Feb; 20(1 Suppl 1):245-8. PubMed ID: 3279615
[No Abstract] [Full Text] [Related]
36. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin.
Merion RM; Howell T; Bromberg JS
Transplantation; 1998 Jun; 65(11):1481-9. PubMed ID: 9645807
[TBL] [Abstract][Full Text] [Related]
37. Polyclonal anti T-lymphocyte antibody therapy monitoring in kidney transplant recipients: comparison of CD3+ T cell and total lymphocyte counts.
Machado FP; Vicari AR; Spuldaro F; Castro Filho JBS; Manfro RC
Einstein (Sao Paulo); 2018 Nov; 16(4):eAO4278. PubMed ID: 30517367
[TBL] [Abstract][Full Text] [Related]
38. Induction in human allograft recipients of unresponsiveness to anti-lymphocyte globulin.
Martin CA; Condie RM; Esquenazi V; Anthone R; Anthone S; Milgrom F
Immunol Invest; 1988 Jun; 17(4):265-72. PubMed ID: 3053435
[TBL] [Abstract][Full Text] [Related]
39. ATGAM associated coagulopathy in renal transplant patients: a report of two unusual cases.
Trivedi HS; Lal SM; Gupta N; Ross G
Int J Artif Organs; 1996 Aug; 19(8):448-50. PubMed ID: 8841842
[TBL] [Abstract][Full Text] [Related]
40. Passively acquired antibody directed at human erythrocytes seen during therapy with Minnesota antilymphoblast globulin.
Wick MR; DeLong EN; Moore SB
Vox Sang; 1985; 48(4):229-34. PubMed ID: 3885573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
